Name: Pediatricians Still Claim That The Hep-B Vaccine Is 'Safe & Effective
Uploaded: 2025-09-26T03:34:20+00:00
Duration: 2 min 5 s
Description: Pediatricians Still Claim That The Hep-B Vaccine Is 'Safe & Effective-Necessary & Needed' For Every Newborn Proven From 'Robust Safety Trials.' The Truth... Recombivax HB: No Placebo & Safety Tested O

22 days ago

169

Health & Science Babies & Kids

Pediatricians Still Claim That The Hep-B Vaccine Is 'Safe & Effective-Necessary & Needed' For Every Newborn Proven From 'Robust Safety Trials.'

The Truth...

Recombivax HB: No Placebo & Safety Tested On 147 Children For 5 Days.

Engerix-B: No Placebo & Safety Tested For 4 Days.

As public concern grows over the large & growing number of shots on the Centers for Disease Control and Prevention (CDC) childhood immunization schedule, the alarm is finally being sounded about the hepatitis B (Hep B) vaccine.

Among the 76 vaccine doses on the schedule, the CDC recommends that every infant born in the U.S. get their first dose of the Hep B vaccine within 12 hours of birth then 2 more doses prior to 6 months of age.

Only 0.69% of pregnant woman test positive for Hep-B prior to delivery yet, every infant is almost forced to be vaccinated for a virus they will never have & in the rare chance of contracting, recovery happens without any long term damage.

According to a records search by attorney Aaron Siri, the Hep B vaccine is required for children to attend childcare & school, yet the CDC has no evidence that Hepatitis B has ever been transmitted in a school setting.

Siri argues the Hep B mandate is about profit, not about protecting children from a contagious disease.

“The Hepatitis B vaccine is a case study in agency capture. All children would not be required to take the shot, he said “if pharma didn’t stand to earn billions through a wider mandate of this product.”

The Hep B vaccine market, valued at more than $8 billion in 2023, is projected to grow to over $13 billion by 2032, with the U.S. making up the largest market for the vaccine.

There are two Hep B vaccines licensed for infants at birth: Merck’s Recombivax HB & GSK’s Engerix-B. Both are made using a genetic engineering technology.

The Recombivax HB label, during clinical trials, 434 doses of the drug were administered to 147 children, who were each monitored for five days.

The Engerix-B package insert doesn’t specify how many babies were included in its clinical trials. However, it does indicate the trial subjects were monitored for only four days.

Peer Reviewed Research Proving Harm From Hep-B Vaccines:
A 2008 study linking Hep B vaccination of male newborns with autism diagnoses at three times the normal rate.

Engerix B vaccine causes CNS inflammatory demyelination — a group of diseases in which the immune system attacks & damages the myelin sheath that protects the brain & spinal cord — resulting in multiple sclerosis in children.

Hep B vaccine has been proven to cause arthritis, acute & chronic ear infections.

Another major concern is dosage:
Hep-B vaccine dosage is the same for newborn infants up to 19 yr old adults. Vaccine dosage doesn’t vary for a 7-pound infant or a 210-pound linebacker.

The dose exposes babies to both the genetically engineered antigen & the aluminum adjuvant 3 times in several weeks post birth.

Aluminum is a heavy metal that’s a proven neurotoxin & crosses the blood-brain barrier. It has scientifically been shown to cause autism, asthma, autoimmune diseases & other horrendous neurological diseases & chronic illnesses.

Infants’ organ membrane barriers are more permeable than those of adults, making them more susceptible to aluminum.

Both US Licensed Hep-B Vaccines Cause The Following Serious Adverse Events:
Herpes
Meningitis
Asthma
Thrombocytopenia
Anaphylaxis
Encephalitis
Multiple sclerosis
Neuritis
Neuropathy
Guillain Barre syndrome
Bell's Palsy
Optic neuritis
Paralysis
Seizures
Syncope
Inflammation of the spinal cord
Heart palpitations
Tachycardia
Apnea
Steven Johnson syndrome
Eczema
Arthritis